Pi Yanan, Huang Wei, Wang Hongyan, Sun Zhenxing, Chi Meng, Guo Liyuan
Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, PR China.
Department of Anesthesia, Harbin Medical University Cancer Hospital, Harbin, PR China.
Ann Med. 2025 Dec;57(1):2534096. doi: 10.1080/07853890.2025.2534096. Epub 2025 Jul 20.
Robotic surgery represents a notable advancement in the field of minimally invasive gynecological surgery. Although the Kangduo Robot® SR1000 (KD-SR-01) surgical system has shown improved stability and high efficiency, studies describing its use for gynecological surgery are limited. We aimed to review the safety and effectiveness of the KD-SR-01 system in gynecologic surgery and compare it with conventional laparoscopic operation.
We compared patient characteristics and short-term outcomes in cases of gynecological surgery conducted using the KD-SR-01 system and laparoscopic minimally invasive procedures between March 2024 and October 2024. The short-term clinical efficacies of both surgical modalities were compared by performing statistical analyses.
The KD-SR-01 system was used for total hysterectomy due to benign uterine tumors in 144 cases, ovarian cyst removal surgery due to benign ovarian tumors in 25 cases, unilateral adnexectomy due to benign ovarian tumors or borderline tumors in 25 cases, staging of early endometrial cancer in 24 cases, and radical cervical cancer resection for early cervical cancer in 24 cases. None of the patients showed serious complications (Clavien-Dindo grade ≥ 3). In comparison with traditional laparoscopic surgery, Kangduo robotic surgery resulted in a lower duration of hospitalization, operation time, blood loss, and drainage volume, but the two surgical modalities showed no differences in the complication rate.
The Kangduo robotic system was safe and feasible for gynecological surgery. Evidence from additional studies and more surgical experience are required to determine the long-term outcomes and indications for gynecological surgery using this robotic system.
机器人手术是微创妇科手术领域的一项显著进展。尽管康多机器人®SR1000(KD-SR-01)手术系统已显示出更高的稳定性和效率,但描述其在妇科手术中应用的研究有限。我们旨在回顾KD-SR-01系统在妇科手术中的安全性和有效性,并将其与传统腹腔镜手术进行比较。
我们比较了2024年3月至2024年10月期间使用KD-SR-01系统进行的妇科手术病例与腹腔镜微创手术病例的患者特征和短期结局。通过统计分析比较了两种手术方式的短期临床疗效。
KD-SR-01系统用于因良性子宫肿瘤行全子宫切除术144例,因良性卵巢肿瘤行卵巢囊肿切除术25例,因良性卵巢肿瘤或交界性肿瘤行单侧附件切除术25例,早期子宫内膜癌分期手术24例,早期宫颈癌根治性子宫切除术24例。所有患者均未出现严重并发症(Clavien-Dindo分级≥3级)。与传统腹腔镜手术相比,康多机器人手术的住院时间、手术时间、失血量和引流量更低,但两种手术方式的并发症发生率无差异。
康多机器人系统在妇科手术中安全可行。需要更多的研究证据和手术经验来确定使用该机器人系统进行妇科手术的长期结局和适应证。